Brian M Culley's Net Worth
$1.49 Million
Who is Brian M Culley?
Brian M Culley has an estimated net worth of $1.49 Million. This is based on reported shares across multiple companies, which include Artemis Therapeutics, Inc., Lineage Cell Therapeutics, Inc., and ADVENTRX PHARMACEUTICALS INC.
SEC CIK
Brian M Culley's CIK is 0001310683
Past Insider Trading and Trends
2022 was Brian M Culley's most active year for acquiring shares with 7 total transactions. Brian M Culley's most active month to acquire stocks was the month of February. 2021 was Brian M Culley's most active year for disposing of shares, totalling 10 transactions. Brian M Culley's most active month to dispose stocks was the month of May. 2021 saw Brian M Culley paying a total of $287,910.00 for 1,526,900 shares, this is the most they've acquired in one year. In 2021 Brian M Culley cashed out on 833,172 shares for a total of $1,345,838.31, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Artemis Therapeutics, Inc. (MNKA) Snapshot price: $0.0021
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Oct 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lineage Cell Therapeutics, Inc. (LCTX) Snapshot price: $0.8778
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +6.90% | 10K |
$1.05 | $10,500.00 | 154.84K |
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
| +14.59% | 18.44K |
$1.08 | -$13,830.48 | 144.84K |
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
| +17.15% | 18.5K |
$1.35 | -$17,204.40 | 126.4K |
Feb 11
| |||
Form 4
| +10.34% | 10.11K |
$1.58 | -$8,441.94 | 107.89K |
Jun 30
| |||
Form 4
| +20.31% | 16.51K |
$1.54 | -$8,228.22 | 97.79K |
Mar 31
| |||
Form 4
| +6.91% | 5.25K |
$1.38 | $7,245.00 | 81.28K |
Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
| +15.33% | 10.11K |
$2.45 | -$13,090.35 | 76.03K |
Dec 31
| |||
Form 4
| +18.11% | 10.11K |
$2.52 | -$13,464.36 | 65.92K |
Sep 30
| |||
Form 4
| -71.48% | -139.89K |
$1.84 | -$1,055,125.05 | 55.82K |
Scheduled
|
Jun 28 - Jun 30
| ||
Form 4
| +5.45% | 10.11K |
$2.35 | $23,751.45 | 195.71K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| +5.76% | 10.11K |
$1.76 | $17,788.32 | 185.6K |
Dec 31
| |||
Form 4
| +6.11% | 10.11K |
$0.94 | $9,466.22 | 175.5K |
Sep 30
| |||
Form 4
| +6.51% | 10.11K |
$0.87 | $8,793.09 | 165.39K |
Jun 30
| |||
Form 4
| +6.96% | 10.11K |
$0.83 | $8,369.60 | 155.28K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
| +7.48% | 10.11K |
$0.89 | -$4,755.27 | 145.17K |
Dec 31
| |||
Form 4
| +8.09% | 10.11K |
$0.98 | -$5,236.14 | 135.07K |
Sep 30
| |||
Form 4
| +47.83% | 40.43K |
$1.00 | -$21,371.00 | 124.96K |
Sep 17
| |||
Form 4
| +13.42% | 10K |
$1.01 | $10,100.00 | 84.53K |
Aug 13
| |||
Form 4
|
∞
| 59.12K |
$0.91 | -$37,323.44 | 59.12K |
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ADVENTRX PHARMACEUTICALS INC (SVRA) Snapshot price: $4.42
CEO and Director
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +146.43% | 20.5K |
$0.59 | $12,103.20 | 34.5K |
Mar 14
| |||
Form 4
|
∞
| 14K |
$0.58 | $8,143.80 | 14K |
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
| -100.00% | -5.00K |
$2.44 | -$12,200.00 |
0
|
Scheduled
|
Jun 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
∞
| 5K |
$1.89 | $9,450.00 | 5K |
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||